MAPT and Alzheimer disease: Immunocytochemistry and biochemical analysis indicate that the ratio of 3R- to 4R-tau altered in AD and other neurodegenerative brain disorders [71–73], although in the normal adult human brain the level of 3R-tau is approximately equal to that of 4R-tau [74].